About: Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
Sector: Healthcare
Industry: Biotechnology
Latest price: $39.57 (+0.82%)
IMVTNASDAQImmunovant Inc
Immunovant Inc share price
IMVT price activity
Last Price
$39.570
Change (24hr)
0.32 USD (0.82%)
Volume
1.51M
Volume (4w avg)
-
Open
$38.59
Day Range
$38.34 - $40.56
Previous Close
$39.25
Last Trade
08 Sep, 8:00 pm GMT+0
Delayed
08 Sep, 8:00 pm GMT+0
IMVT price performance
Delayed
08 Sep, 8:00 pm GMT+0
IMVT Market Signals